| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1302.b | Amgros I/S | Macure Pharma ApS, Navamedic AB, Navamedic AB, Macure Pharma ApS, XGX Pharma ApS, Orifarm A/S, Macure Pharma ApS, Orifarm A/S, 2care4 ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Navamedic AB, Hameln Pharma ApS, Navamedic AB, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Hameln Pharma ApS, Pfizer ApS, Orifarm A/S, MSD Danmark ApS, Hameln Pharma ApS, FrostPharma AB, Orifarm A/S, B. Braun Medical A/S, FrostPharma AB, Baxter A/S, Hameln Pharma ApS, Accord Healthcare AB, Hameln Pharma ApS, Accord Healthcare AB | 193.377.429 kr. | 29. oktober 2026 |
| Amgros 2027 2.1301.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, Zambon Sweden, filial of Zambon Nederland B.V, Zambon Sweden, filial of Zambon Nederland B.V | 45.360.361 kr. | 29. oktober 2026 |
| Amgros 2027 2.1301.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, Zambon Sweden, filial of Zambon Nederland B.V, Zambon Sweden, filial of Zambon Nederland B.V | 45.360.361 kr. | 29. oktober 2026 |
| Amgros 2027 2.1301.a | Amgros I/S | Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, Zambon Sweden, filial of Zambon Nederland B.V, Zambon Sweden, filial of Zambon Nederland B.V | 45.360.361 kr. | 29. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 2.290.b | Amgros I/S | Orifarm Generics A/S, Orifarm A/S, Abacus Medicine A/S, Krka Sverige AB, Zentiva Denmark ApS, Krka Sverige AB, Sandoz A/S, Orifarm Generics A/S, EQL Pharma AB, 2care4 ApS, 2care4 ApS, Abcur AB, 2care4 Generics ApS, Orifarm A/S, Abcur AB, Norgine Danmark A/S, Macure Pharma ApS, 2care4 ApS, Macure Pharma ApS, STADA Nordic ApS, Orifarm Generics A/S, 2care4 Generics ApS, 2care4 Generics ApS | 46.249.452 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 1.604.a | Amgros I/S | Viatris ApS, Sandoz A/S, Abcur AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Glenmark Pharmaceuticals Nordic AB, Krka Sverige AB, Glenmark Pharmaceuticals Nordic AB, Teva Denmark A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Otsuka Pharma Scandinavia AB, Macure Pharma ApS, Macure Pharma ApS, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Neuraxpharm Sweden AB, Orifarm A/S | 284.601.687 kr. | 25. oktober 2026 |
| Amgros 2027 2.1303.b | Amgros I/S | 2care4 Generics ApS, 2care4 Generics ApS, EQL Pharma AB, Macure Pharma ApS, Nordic Prime ApS | 5.735.454 kr. | 21. oktober 2026 |
| Amgros 2027 1.1202.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Orifarm Generics A/S, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Aguettant Nordic ApS, Orifarm A/S, STADA Nordic ApS, Fresenius Kabi, Filial af Fresenius Kabi AB, Sverige, Øresund Pharma ApS, Sun Pharmaceuticals Germany GmbH | 381.745.570 kr. | 21. oktober 2026 |
| Amgros 2027 1.601.a | Amgros I/S | Unimedic Pharma AB, Abacus Medicine A/S, Orifarm A/S, Macure Pharma ApS, 2care4 ApS, 2care4 ApS, Abacus Medicine A/S, Abacus Medicine A/S, Abacus Medicine A/S | 75.178.698 kr. | 20. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.701.a | Amgros I/S | Macure Pharma ApS, B. Braun Medical A/S, Macure Pharma ApS, Vantive ApS, Vantive ApS, Orifarm A/S, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Sun Pharmaceuticals Germany GmbH, Amgen Filial Af Amgen Ab Sverige, Galderma Nordic AB, Galenica AB, Medac Gesellschaft für klinische Spezialpräparate G.m.b.H, Tyskland, filial, Orion Pharma A/S, Teva Denmark A/S, Strides Nordic ApS, GHN Pharma Nordic AB, Macure Pharma ApS, Novartis Healthcare A/S, Zentiva Denmark ApS, Zentiva Denmark ApS, Orion Pharma A/S | 899.151.051 kr. | 15. oktober 2026 |
| Amgros 2027 1.1203.a | Amgros I/S | Navamedic AB, Hameln Pharma ApS, Macure Pharma ApS, Hameln Pharma ApS, Orifarm A/S, 2care4 ApS, Viatris ApS, Glenmark Pharmaceuticals Nordic AB, Øresund Pharma ApS, Sandoz A/S, Orifarm A/S, Paranova Danmark A/S, Vingmed A/S, Abacus Medicine A/S, Paranova Danmark A/S | 148.085.649 kr. | 13. oktober 2026 |
| Amgros 2027 1.202.a | Amgros I/S | 2care4 ApS, Abacus Medicine A/S, Teva Denmark A/S, Macure Pharma ApS | 33.940.957 kr. | 13. oktober 2026 |
| Amgros 2027 1.1205.b | Amgros I/S | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS | 43.986.317 kr. | 13. oktober 2026 |
| Amgros 2027 1.1205.b | Amgros I/S | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS | 43.986.317 kr. | 13. oktober 2026 |
| Amgros 2027 1.1205.b | Amgros I/S | Hameln Pharma ApS, Orifarm A/S, Abcur AB, Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS | 43.986.317 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 2.1200.a | Amgros I/S | Macure Pharma ApS, Macure Pharma ApS, Macure Pharma ApS, Orifarm A/S, Orifarm A/S, Aguettant Nordic ApS, Aguettant Nordic ApS, Zentiva Denmark ApS, Aguettant Nordic ApS, Øresund Pharma ApS, Macure Pharma ApS, Orifarm A/S, Macure Pharma ApS, GE Healthcare A/S, Accord Healthcare AB, Accord Healthcare AB, Abcur AB, Paranova Danmark A/S, 2care4 ApS | 73.487.895 kr. | 13. oktober 2026 |
| Amgros 2027 1.700.a | Amgros I/S | Macure Pharma ApS, Swedish Orphan Biovitrum AB, Swedish Orphan Biovitrum AB, Orifarm Generics A/S, Recordati AB, Viatris ApS, Orifarm A/S, Ferring Lægemidler A/S, Orifarm A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Ferring Lægemidler A/S, Orion Pharma A/S, Orion Pharma A/S, Ferring Lægemidler A/S, Orifarm A/S, Viatris ApS, AstraZeneca A/S, AstraZeneca A/S, FrostPharma AB, FrostPharma AB, Sanofi A/S, BioMarin International Limited, Takeda Pharma A/S, BioMarin International Limited, Chiesi Pharma AB, Øresund Pharma ApS, Takeda Pharma A/S, Viatris ApS, Øresund Pharma ApS | 419.427.587 kr. | 12. oktober 2026 |